GIST Awareness Day – Mumbai, India
Patient Support Group meeting on GIST Awareness Day in Mumbai, India, 2019.
Patient Support Group meeting on GIST Awareness Day in Mumbai, India, 2019.
Blueprint Medicines hosted a webinar for the GIST patient and caregiver community about Avapritinib, an investigational medicine for people with advanced GIST.
GIST Awareness Day in Argentina, Guatemala, Honduras, and Peru, 2019. GAD began in 2014 by The Life Raft Group, to raise awareness on GIST worldwide.
GIST Awareness Day in Colombia, 2019. GAD began in 2014 by The Life Raft Group, to raise awareness on GIST worldwide.
GIST Awareness Day in Spain, 2019. GAD began in 2014 by The Life Raft Group, to raise awareness on GIST worldwide.
GIST Awareness Day in Chile, 2019. GAD began in 2014 by The Life Raft Group, to raise awareness on GIST worldwide.
GIST DO IT is an amazing way to educate the medical community and the general public about GIST. We would like to take it to the next level and encourage everyone to “GIST DO IT All Year Long.”
The FDA granted the approval of Rozlytrek™ (entrectinib) for the treatment of adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC), The FDA has also granted accelerated approval to Rozlytrek for the treatment of [...]
Deciphera Pharmaceuticals has released positive results from their INVICTUS Phase 3 Clinical Study of Ripretinib in patients with GIST. They have also updated results from the Phase 1 Study. Deciphera shared that "patients treated [...]
The latest issue of LRG Science is titled, "Patient-reported Treatment Responses in Known/Likely SDH-deficient GISTS: An Analysis of The Life Raft Group Observational Registry." This study highlights the very unique research role that defines The Life Raft Group. Subscribe to LRG Science by emailing mgarland@liferaftgroup.org with the subject line SUBSCRIBE LRG SCIENCE.